Thomas J. Herzfeld Advisors, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 335 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
Thomas J. Herzfeld Advisors, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$61,880
-1.5%
4,0000.0%0.02%
-4.0%
Q2 2023$62,840
-4.7%
4,0000.0%0.02%
-7.4%
Q1 2023$65,920
+5.6%
4,0000.0%0.03%
+3.8%
Q4 2022$62,400
+20.0%
4,0000.0%0.03%
+18.2%
Q3 2022$52,000
-7.1%
4,0000.0%0.02%
-4.3%
Q2 2022$56,000
-1.8%
4,0000.0%0.02%
+9.5%
Q1 2022$57,000
+3.6%
4,0000.0%0.02%
+5.0%
Q4 2021$55,000
-16.7%
4,0000.0%0.02%
-31.0%
Q3 2021$66,000
-1.5%
4,0000.0%0.03%
+3.6%
Q2 2021$67,000
-8.2%
4,0000.0%0.03%
-15.2%
Q1 2021$73,0000.0%4,0000.0%0.03%
-2.9%
Q4 2020$73,000
+17.7%
4,0000.0%0.03%
-19.0%
Q3 2020$62,000
-15.1%
4,0000.0%0.04%
+16.7%
Q2 2020$73,000
+12.3%
4,000
-6.5%
0.04%
+2.9%
Q1 2020$65,000
-22.6%
4,2790.0%0.04%
+16.7%
Q4 2019$84,000
+13.5%
4,2790.0%0.03%
+11.1%
Q3 2019$74,000
-5.1%
4,279
-2.7%
0.03%
-10.0%
Q2 2019$78,000
-3.7%
4,396
+9.9%
0.03%0.0%
Q1 2019$81,000
+20.9%
4,0000.0%0.03%
+11.1%
Q4 2018$67,0004,0000.03%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2019
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders